HomeAKRO • NASDAQ
add
Akero Therapeutics Inc
Previous close
$41.68
Day range
$41.61 - $43.92
Year range
$17.86 - $58.40
Market cap
3.28B USD
Avg Volume
1.74M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 78.02M | 26.11% |
Net income | -70.02M | -26.89% |
Net profit margin | — | — |
Earnings per share | -0.99 | 0.00% |
EBITDA | -78.01M | -26.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 743.08M | 35.10% |
Total assets | 825.89M | 42.33% |
Total liabilities | 75.77M | 68.52% |
Total equity | 750.11M | — |
Shares outstanding | 79.62M | — |
Price to book | 4.02 | — |
Return on assets | -23.74% | — |
Return on capital | -25.00% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -70.02M | -26.89% |
Cash from operations | -67.09M | -37.97% |
Cash from investing | 15.27M | 19.44% |
Cash from financing | 75.99M | 15,037.65% |
Net change in cash | 24.17M | 168.40% |
Free cash flow | -43.36M | -48.42% |
About
Founded
2017
Headquarters
Website
Employees
63
